Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion

Nutrition and Metabolism

Volumn 7, Issue , 2010, Pages

  Sundaram, Meenakshi ^a   Yao, Zemin ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; FATTY ACID; GLYCEROLIPID; INSULIN; LIPOPROTEIN RECEPTOR; LIVER PROTEIN; TRIACYLGLYCEROL; TRIACYLGLYCEROL RICH VERY LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

BIOGENESIS; CELL METABOLISM; CELL MIGRATION; CYTOSOL; HUMAN; HYPOBETALIPOPROTEINEMIA; LIPOPROTEIN SECRETION; MUTATION; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

EID: 77951228960     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-7-35     Document Type: Review

References (173)

1. Human apolipoprotein B-100: cloning, analysis of liver mRNA, and assignment of the gene to chromosome 2. Law SW, Lackner KJ, Hospattankar AV, Anchors JM, Sakaguchi AY, Naylor SL, Brewer HB Jr, Proc Natl Acad Sci USA 1985 82 8340 8344 10.1073/pnas.82.24.8340 3001697 (Pubitemid 16101074)
2. Cloning and expression of apolipoprotein B, the major protein of low and very low density lipoproteins. Lusis AJ, West R, Mehrabian M, Reuben MA, LeBoeuf RC, Kaptein JS, Johnson DF, Schumaker VN, Yuhasz MP, Schotz MC, et al. Proc Natl Acad Sci USA 1985 82 4597 4601 10.1073/pnas.82.14.4597 3860811 (Pubitemid 16239610)
3. Chromosomal localization of the human apolipoprotein B gene and detection of homologous RNA in monkey intestine. Deeb SS, Disteche C, Motulsky AG, Lebo RV, Kan YW, Proc Natl Acad Sci USA 1986 83 419 422 10.1073/pnas.83.2.419 3455779 (Pubitemid 16080024)
4. Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Chen SH, Habib G, Yang CY, Gu ZW, Lee BR, Weng SA, Silberman SR, Cai SJ, Deslypere JP, Rosseneu M, et al. Science 1987 238 363 366 10.1126/science.3659919 3659919 (Pubitemid 17151728)
5. Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons. Kane JP, Hardman DA, Paulus HE, Proc Natl Acad Sci USA 1980 77 2465 2469 10.1073/pnas.77.5.2465 6930644
6. Expression of apolipoprotein B mRNAs encoding higher- and lower-molecular weight isoproteins in rat liver and intestine. Tennyson GE, Sabatos CA, Higuchi K, Meglin N, Brewer HB Jr, Proc Natl Acad Sci USA 1989 86 500 504 10.1073/pnas.86.2.500 2911593 (Pubitemid 19037773)
7. Structure of apolipoprotein B-100 in low density lipoproteins. Segrest JP, Jones MK, De LH, Dashti N, J Lipid Res 2001 42 1346 1367 11518754 (Pubitemid 34007665)
8. The structure of vitellogenin provides a molecular model for the assembly and secretion of atherogenic lipoproteins. Mann CJ, Anderson TA, Read J, Chester SA, Harrison GB, Kochl S, Ritchie PJ, Bradbury P, Hussain FS, Amey J, et al. J Mol Biol 1999 285 391 408 10.1006/jmbi.1998.2298 9878414 (Pubitemid 29034052)
9. Defining lipid-interacting domains in the N-terminal region of apolipoprotein B. Jiang ZG, Gantz D, Bullitt E, McKnight CJ, Biochemistry 2006 45 11799 11808 10.1021/bi060600w 17002280 (Pubitemid 44497807)
10. The N-terminal 1000 residues of apolipoprotein B associate with microsomal triglyceride transfer protein to create a lipid transfer pocket required for lipoprotein assembly. Dashti N, Gandhi M, Liu X, Lin X, Segrest JP, Biochemistry 2002 41 6978 6987 10.1021/bi011757l 12033930 (Pubitemid 34575669)
11. Structural analysis of reconstituted lipoproteins containing the N-terminal domain of apolipoprotein B. Jiang ZG, Simon MN, Wall JS, McKnight CJ, Biophys J 2007 92 4097 4108 10.1529/biophysj.106.101105 17369413 (Pubitemid 46910594)
12. Model of human low-density lipoprotein and bound receptor based on cryoEM. Ren G, Rudenko G, Ludtke SJ, Deisenhofer J, Chiu W, Pownall HJ, Proc Natl Acad Sci USA 2010 107 1059 1064 10.1073/pnas.0908004107 20080547
13. Amino acids 430-570 in apolipoprotein B are critical for its binding to microsomal triglyceride transfer protein. Hussain MM, Bakillah A, Nayak N, Shelness GS, J Biol Chem 1998 273 25612 25615 10.1074/jbc.273.40.25612 9748226 (Pubitemid 28475781)
14. N-terminal domain of apolipoprotein B has structural homology to lipovitellin and microsomal triglyceride transfer protein: a "lipid pocket" model for self-assembly of apob-containing lipoprotein particles. Segrest JP, Jones MK, Dashti N, J Lipid Res 1999 40 1401 1416 10428976 (Pubitemid 29379980)
15. Microsomal triglyceride transfer protein binding and lipid transfer activities are independent of each other, but both are required for secretion of apolipoprotein B lipoproteins from liver cells. Liang J, Ginsberg HN, J Biol Chem 2001 276 28606 28612 10.1074/jbc.M100294200 11358959
16. A common binding site on the microsomal triglyceride transfer protein for apolipoprotein B and protein disulfide isomerase. Bradbury P, Mann CJ, Kochl S, Anderson TA, Chester SA, Hancock JM, Ritchie PJ, Amey J, Harrison GB, Levitt DG, et al. J Biol Chem 1999 274 3159 3164 10.1074/jbc.274.5.3159 9915855 (Pubitemid 29075404)
17. Apolipoprotein B binding to microsomal triglyceride transfer protein decreases with increases in length and lipidation: implications in lipoprotein biosynthesis. Hussain MM, Bakillah A, Jamil H, Biochemistry 1997 36 13060 13067 10.1021/bi971395a 9335568 (Pubitemid 27465421)
18. Amino terminus of apolipoprotein B suffices to produce recognition of malondialdehyde-modified low density lipoprotein by the scavenger receptor of human monocyte-macrophages. Kreuzer J, White AL, Knott TJ, Jien ML, Mehrabian M, Scott J, Young SG, Haberland ME, J Lipid Res 1997 38 324 342 9162752 (Pubitemid 27118045)
19. An amino-terminal fragment of apolipoprotein B binds to lipoprotein lipase and may facilitate its binding to endothelial cells. Sivaram P, Choi SY, Curtiss LK, Goldberg IJ, J Biol Chem 1994 269 9409 9412 8144523 (Pubitemid 24196527)
20. Identification of the lipoprotein initiating domain of apolipoprotein B. Shelness GS, Hou L, Ledford AS, Parks JS, Weinberg RB, J Biol Chem 2003 278 44702 44707 10.1074/jbc.M307562200 12941937 (Pubitemid 37377227)
21. Surface study of apoB1694-1880, a sequence that can anchor apoB to lipoproteins and make it nonexchangeable. Wang L, Martin DD, Genter E, Wang J, McLeod RS, Small DM, J Lipid Res 2009 50 1340 1352 10.1194/jlr.M900040-JLR200 19251580
22. Identification of low density lipoprotein receptor binding domains of human apolipoprotein B-100: a proposed consensus LDL receptor binding sequence of apoB-100. Hospattankar AV, Law SW, Lackner K, Brewer HB Jr, Biochem Biophys Res Commun 1986 139 1078 1085 10.1016/S0006-291X(86)80287-X 3767991 (Pubitemid 17168498)
23. Sequence, structure, receptor-binding domains and internal repeats of human apolipoprotein B-100. Yang CY, Chen SH, Gianturco SH, Bradley WA, Sparrow JT, Tanimura M, Li WH, Sparrow DA, DeLoof H, Rosseneu M, et al. Nature 1986 323 738 742 10.1038/323738a0 3095664 (Pubitemid 17172977)
24. Apolipoprotein B is conformationally flexible but anchored at a triolein/water interface: a possible model for lipoprotein surfaces. Wang L, Walsh MT, Small DM, Proc Natl Acad Sci USA 2006 103 6871 6876 10.1073/pnas.0602213103 16636271
25. The amino terminus of apolipoprotein B is necessary but not sufficient for microsomal triglyceride transfer protein responsiveness. Gretch DG, Sturley SL, Wang L, Lipton BA, Dunning A, Grunwald KA, Wetterau JR, Yao Z, Talmud P, Attie AD, J Biol Chem 1996 271 8682 8691 10.1074/jbc.271.15.8682 8621500 (Pubitemid 26123284)
26. Apolipoprotein B sequence requirements for hepatic very low density lipoprotein assembly. Evidence that hydrophobic sequences within apolipoprotein B48 mediate lipid recruitment. McLeod RS, Wang Y, Wang S, Rusinol A, Links P, Yao Z, J Biol Chem 1996 271 18445 18455 10.1074/jbc.271.24.14124 8702489 (Pubitemid 26190308)
27. Translocation efficiency, susceptibility to proteasomal degradation, and lipid responsiveness of apolipoprotein B are determined by the presence of beta sheet domains. Liang J, Wu X, Jiang H, Zhou M, Yang H, Angkeow P, Huang LS, Sturley SL, Ginsberg H, J Biol Chem 1998 273 35216 35221 10.1074/jbc.273.52. 35216 9857060 (Pubitemid 29028227)
28. Functional analysis of disulfide linkages clustered within the amino terminus of human apolipoprotein B. Tran K, Boren J, Macri J, Wang Y, McLeod R, Avramoglu RK, Adeli K, Yao Z, J Biol Chem 1998 273 7244 7251 10.1074/jbc.273.13.7244 9516417 (Pubitemid 28152741)
29. Identification of cysteine pairs within the amino-terminal 5% of apolipoprotein B essential for hepatic lipoprotein assembly and secretion. Huang XF, Shelness GS, J Biol Chem 1997 272 31872 31876 10.1074/jbc.272.50.31872 9395534 (Pubitemid 28013339)
30. Apolipoprotein B-100 destined for lipoprotein assembly and intracellular degradation undergoes efficient translocation across the endoplasmic reticulum membrane. Ingram MF, Shelness GS, J Lipid Res 1996 37 2202 2214 8906597 (Pubitemid 26357331)
31. The structures of the asparagine-linked sugar chains of human apolipoprotein B-100. Taniguchi T, Ishikawa Y, Tsunemitsu M, Fukuzaki H, Arch Biochem Biophys 1989 273 197 205 10.1016/0003-9861(89)90179-3 2757392 (Pubitemid 19197907)
32. The N-linked oligosaccharides at the amino terminus of human apoB are important for the assembly and secretion of VLDL. Vukmirica J, Nishimaki-Mogami T, Tran K, Shan J, McLeod RS, Yuan J, Yao Z, J Lipid Res 2002 43 1496 1507 10.1194/jlr.M200077-JLR200 12235182
33. Signalling functions of protein palmitoylation. Dunphy JT, Linder ME, Biochim Biophys Acta 1998 1436 245 261 9838145
34. Apolipoprotein B synthesized by Hep G2 cells undergoes fatty acid acylation. Hoeg JM, Meng MS, Ronan R, Demosky SJ Jr, Fairwell T, Brewer HB Jr, J Lipid Res 1988 29 1215 1220 2846736
35. Palmitoylation of apolipoprotein B is required for proper intracellular sorting and transport of cholesteroyl esters and triglycerides. Zhao Y, McCabe JB, Vance J, Berthiaume LG, Mol Biol Cell 2000 11 721 734 10679026 (Pubitemid 30112177)
36. Assembly and secretion of very low density lipoproteins containing apolipoprotein B48 in transfected McA-RH7777 cells. Lack of evidence that palmitoylation of apolipoprotein B48 is required for lipoprotein secretion. Vukmirica J, Tran K, Liang X, Shan J, Yuan J, Miskie BA, Hegele RA, Resh MD, Yao Z, J Biol Chem 2003 278 14153 14161 10.1074/jbc.M211995200 12582154 (Pubitemid 36799962)
37. Familial hypobetalipoproteinemia: a review. Schonfeld G, J Lipid Res 2003 44 878 883 10.1194/jlr.R300002-JLR200 12639976 (Pubitemid 37279647)
38. Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study. Heiss G, Tamir I, Davis CE, Tyroler HA, Rifkand BM, Schonfeld G, Jacobs D, Frantz ID Jr, Circulation 1980 61 302 315 7351055 (Pubitemid 10214988)
39. Apolipoprotein B-32: a new truncated mutant of human apolipoprotein B capable of forming particles in the low density lipoprotein range. McCormick SP, Fellowes AP, Walmsley TA, George PM, Biochim Biophys Acta 1992 1138 290 296 1562615
40. ApoB-54.8, a truncated apolipoprotein found primarily in VLDL, is associated with a nonsense mutation in the apoB gene and hypobetalipoproteinemia. Wagner RD, Krul ES, Tang J, Parhofer KG, Garlock K, Talmud P, Schonfeld G, J Lipid Res 1991 32 1001 1011 1940616
41. Two apolipoprotein B gene defects in a kindred with hypobetalipoproteinemia, one of which results in a truncated variant, apoB-61, in VLDL and LDL. Pullinger CR, Hillas E, Hardman DA, Chen GC, Naya-Vigne JM, Iwasa JA, Hamilton RL, Lalouel JM, Williams RR, Kane JP, J Lipid Res 1992 33 699 710 1619363
42. ApoB-75, a truncation of apolipoprotein B associated with familial hypobetalipoproteinemia: genetic and kinetic studies. Krul ES, Parhofer KG, Barrett PH, Wagner RD, Schonfeld G, J Lipid Res 1992 33 1037 1050 1431583
43. A truncated species of apolipoprotein B, B-83, associated with hypobetalipoproteinemia. Farese RV Jr, Garg A, Pierotti VR, Vega GL, Young SG, J Lipid Res 1992 33 569 577 1527480
44. High frequency of APOB gene mutations causing familial hypobetalipoproteinaemia in patients of Dutch and Spanish descent. Fouchier SW, Sankatsing RR, Peter J, Castillo S, Pocovi M, Alonso R, Kastelein JJ, Defesche JC, J Med Genet 2005 42 23 10.1136/jmg.2004.029454 15805152
45. Hypobetalipoproteinemic mice with a targeted apolipoprotein (Apo) B-27.6-specifying mutation: in vivo evidence for an important role of amino acids 1254-1744 of ApoB in lipid transport and metabolism of the apoB-containing lipoprotein. Chen Z, Fitzgerald RL, Schonfeld G, J Biol Chem 2002 277 14135 14145 11839763 (Pubitemid 34968025)
46. Carboxyl-terminal truncation impairs lipid recruitment by apolipoprotein B100 but does not affect secretion of the truncated apolipoprotein B-containing lipoproteins. McLeod RS, Zhao Y, Selby SL, Westerlund J, Yao Z, J Biol Chem 1994 269 2852 2862 8300620
47. A novel nontruncating APOB gene mutation, R463W, causes familial hypobetalipoproteinemia. Burnett JR, Shan J, Miskie BA, Whitfield AJ, Yuan J, Tran K, McKnight CJ, Hegele RA, Yao Z, J Biol Chem 2003 278 13442 13452 10.1074/jbc.M300235200 12551903 (Pubitemid 36800118)
48. Missense mutations in APOB within the betaalpha1 domain of human APOB-100 result in impaired secretion of ApoB and ApoB-containing lipoproteins in familial hypobetalipoproteinemia. Burnett JR, Zhong S, Jiang ZG, Hooper AJ, Fisher EA, McLeod RS, Zhao Y, Barrett PH, Hegele RA, van Bockxmeer FM, et al. J Biol Chem 2007 282 24270 24283 10.1074/jbc.M702442200 17588943 (Pubitemid 47328026)
49. Molecular diagnosis of hypobetalipoproteinemia: an ENID review. Tarugi P, Averna M, Di LE, Cefalu AB, Noto D, Magnolo L, Cattin L, Bertolini S, Calandra S, Atherosclerosis 2007 195 19 e27 10.1016/j.atherosclerosis.2007.05.003 17570373 (Pubitemid 350087974)
50. Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein B. Zhong S, Magnolo AL, Sundaram M, Zhou H, Yao EF, Di LE, Loria P, Wang S, Bamji-Mirza M, Wang L, et al. J Biol Chem 2010 285 6453 6464 10.1074/jbc.M109.060467 20032471
51. Microsomal triglyceride transfer protein. Specificity of lipid binding and transport. Jamil H, Dickson JK Jr, Chu CH, Lago MW, Rinehart JK, Biller SA, Gregg RE, Wetterau JR, J Biol Chem 1995 270 6549 6554 10.1074/jbc.270.12.6549 7896791
52. Protein disulfide isomerase is a component of the microsomal triglyceride transfer protein complex. Wetterau JR, Combs KA, Spinner SN, Joiner BJ, J Biol Chem 1990 265 9800 9807 2351674
53. The enzymatic and non-enzymatic roles of protein-disulfide isomerase in apolipoprotein B secretion. Wang L, Fast DG, Attie AD, J Biol Chem 1997 272 27644 27651 10.1074/jbc.272.44.27644 9346903 (Pubitemid 27473558)
54. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Wetterau JR, Aggerbeck LP, Bouma ME, Eisenberg C, Munck A, Hermier M, Schmitz J, Gay G, Rader DJ, Gregg RE, Science 1992 258 999 1001 10.1126/science.1439810 1439810
55. A mechanism of membrane neutral lipid acquisition by the microsomal triglyceride transfer protein. Read J, Anderson TA, Ritchie PJ, Vanloo B, Amey J, Levitt D, Rosseneu M, Scott J, Shoulders CC, J Biol Chem 2000 275 30372 30377 10.1074/jbc.C000364200 10893406
56. Regulated Co-translational ubiquitination of apolipoprotein B100. A new paradigm for proteasomal degradation of a secretory protein. Zhou M, Fisher EA, Ginsberg HN, J Biol Chem 1998 273 24649 24653 10.1074/jbc.273.38.24649 9733761 (Pubitemid 28454962)
57. The activity of microsomal triglyceride transfer protein is essential for accumulation of triglyceride within microsomes in McA-RH7777 cells. A unified model for the assembly of very low density lipoproteins. Wang Y, Tran K, Yao Z, J Biol Chem 1999 274 27793 27800 10.1074/jbc.274.39.27793 10488124 (Pubitemid 29458032)
58. The microsomal triglyceride transfer protein catalyzes the post-translational assembly of apolipoprotein B-100 very low density lipoprotein in McA-RH7777 cells. Rustaeus S, Stillemark P, Lindberg K, Gordon D, Olofsson SO, J Biol Chem 1998 273 5196 5203 10.1074/jbc.273.9.5196 9478974 (Pubitemid 28108682)
59. Progress towards understanding the role of microsomal triglyceride transfer protein in apolipoprotein-B lipoprotein assembly. Gordon DA, Jamil H, Biochim Biophys Acta 2000 1486 72 83 10856714 (Pubitemid 30336793)
60. Normal activity of microsomal triglyceride transfer protein is required for the oleate-induced secretion of very low density lipoproteins containing apolipoprotein B from McA-RH7777 cells. Wang Y, McLeod RS, Yao Z, J Biol Chem 1997 272 12272 12278 10.1074/jbc.272.19.12272 9139669 (Pubitemid 27203310)
61. Microsomal triacylglycerol transfer protein is required for lumenal accretion of triacylglycerol not associated with ApoB, as well as for ApoB lipidation. Kulinski A, Rustaeus S, Vance JE, J Biol Chem 2002 277 31516 31525 10.1074/jbc.M202015200 12072432 (Pubitemid 34968953)
62. Inactivation of microsomal triglyceride transfer protein impairs the normal redistribution but not the turnover of newly synthesized glycerolipid in the cytosol, endoplasmic reticulum and Golgi of primary rat hepatocytes. Hebbachi A, Gibbons GF, Biochim Biophys Acta 1999 1441 36 50 10526226 (Pubitemid 29469435)
63. Liver-specific inactivation of the abetalipoproteinemia gene completely abrogates very low density lipoprotein/low density lipoprotein production in a viable conditional knockout mouse. Chang BH, Liao W, Li L, Nakamuta M, Mack D, Chan L, J Biol Chem 1999 274 6051 6055 10.1074/jbc.274.10.6051 10037685 (Pubitemid 29111008)
64. Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. Raabe M, Veniant MM, Sullivan MA, Zlot CH, Bjorkegren J, Nielsen LB, Wong JS, Hamilton RL, Young SG, J Clin Invest 1999 103 1287 1298 10.1172/JCI6576 10225972 (Pubitemid 29218299)
65. Coordinate transcriptional repression of liver fatty acid-binding protein and microsomal triglyceride transfer protein blocks hepatic very low density lipoprotein secretion without hepatosteatosis. Spann NJ, Kang S, Li AC, Chen AZ, Newberry EP, Davidson NO, Hui ST, Davis RA, J Biol Chem 2006 281 33066 33077 10.1074/jbc.M607148200 16950764 (Pubitemid 46036689)
66. Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver. Huang J, Iqbal J, Saha PK, Liu J, Chan L, Hussain MM, Moore DD, Wang L, Hepatology 2007 46 147 157 10.1002/hep.21632 17526026 (Pubitemid 47171931)
67. Regulation of insulin-like growth factor-dependent myoblast differentiation by Foxo forkhead transcription factors. Hribal ML, Nakae J, Kitamura T, Shutter JR, Accili D, J Cell Biol 2003 162 535 541 10.1083/jcb.200212107 12925703 (Pubitemid 37022932)
68. FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. Kamagate A, Qu S, Perdomo G, Su D, Kim DH, Slusher S, Meseck M, Dong HH, J Clin Invest 2008 118 2347 2364 18497885 (Pubitemid 351872351)
69. Coactivation of Foxa2 through Pgc-1beta promotes liver fatty acid oxidation and triglyceride/VLDL secretion. Wolfrum C, Stoffel M, Cell Metab 2006 3 99 110 10.1016/j.cmet.2006.01.001 16459311
70. Regulation of the enzymes of hepatic microsomal triacylglycerol lipolysis and re-esterification by the glucocorticoid dexamethasone. Dolinsky VW, Douglas DN, Lehner R, Vance DE, Biochem J 2004 378 967 974 10.1042/BJ20031320 14662008 (Pubitemid 38406874)
71. The assembly of very low density lipoproteins in rat hepatoma McA-RH7777 cells is inhibited by phospholipase A2 antagonists. Tran K, Wang Y, DeLong CJ, Cui Z, Yao Z, J Biol Chem 2000 275 25023 25030 10.1074/jbc.M908971199 10827200 (Pubitemid 30626612)
72. Attenuated secretion of very low density lipoproteins from McA-RH7777 cells treated with eicosapentaenoic acid is associated with impaired utilization of triacylglycerol synthesized via phospholipid remodeling. Tran K, Sun F, Cui Z, Thorne-Tjomsland G, St GC, Lapierre LR, McLeod RS, Jamieson JC, Yao Z, Biochim Biophys Acta 2006 1761 463 473 16675301 (Pubitemid 43776457)
73. Hepatic uptake and metabolism of phosphatidylcholine associated with high density lipoproteins. Robichaud JC, van d V, Yao Z, Trigatti B, Vance DE, Biochim Biophys Acta 2009 1790 538 551 19250958
74. Impairment of VLDL secretion by medium-chain fatty acids in chicken primary hepatocytes is affected by the chain length. Sato K, Cho Y, Tachibana S, Chiba T, Schneider WJ, Akiba Y, J Nutr 2005 135 1636 1641 15987842 (Pubitemid 40980711)
75. Octanoate reduces very low-density lipoprotein secretion by decreasing the synthesis of apolipoprotein B in primary cultures of chicken hepatocytes. Tachibana S, Sato K, Cho Y, Chiba T, Schneider WJ, Akiba Y, Biochim Biophys Acta 2005 1737 36 43 16226916 (Pubitemid 41550381)
76. Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions. Sundaram M, Zhong S, Bou Khalil M, Links PH, Zhao Y, Iqbal J, Hussain MM, Parks RJ, Wang Y, Yao Z, J Lipid Res 2010 51 150 161 10.1194/M900346-JLR200 19622837
77. Intracellular assembly of very low density lipoproteins containing apolipoprotein B100 in rat hepatoma McA-RH7777 cells. Tran K, Thorne-Tjomsland G, DeLong CJ, Cui Z, Shan J, Burton L, Jamieson JC, Yao Z, J Biol Chem 2002 277 31187 31200 10.1074/jbc.M200249200 12065576 (Pubitemid 34970825)
78. Presecretory oxidation, aggregation, and autophagic destruction of apoprotein-B: a pathway for late-stage quality control. Pan M, Maitin V, Parathath S, Andreo U, Lin SX, St GC, Yao Z, Maxfield FR, Williams KJ, Fisher EA, Proc Natl Acad Sci USA 2008 105 5862 5867 10.1073/pnas.0707460104 18391222 (Pubitemid 351758463)
79. Differential influence of different dietary fatty acids on very low-density lipoprotein secretion when delivered to hepatocytes in chylomicron remnants. Lopez-Soldado I, Avella M, Botham KM, Metabolism 2009 58 186 195 10.1016/j.metabol.2008.09.012 19154951
80. Conjugated linoleic acid suppresses the secretion of atherogenic lipoproteins from human HepG2 liver cells. Pal S, Takechi R, Ho SS, Clin Chem Lab Med 2005 43 269 274 10.1515/CCLM.2005.045 15843229
81. Echium oil reduces plasma lipids and hepatic lipogenic gene expression in apoB100-only LDL receptor knockout mice. Zhang P, Boudyguina E, Wilson MD, Gebre AK, Parks JS, J Nutr Biochem 2008 19 655 663 10.1016/j.jnutbio.2007.08.005 18155507
82. Essential fatty acid deficiency in mice is associated with hepatic steatosis and secretion of large VLDL particles. Werner A, Havinga R, Bos T, Bloks VW, Kuipers F, Verkade HJ, Am J Physiol Gastrointest Liver Physiol 2005 288 1150 G1158 10.1152/ajpgi.00456.2004 15662048 (Pubitemid 40741067)
83. Upregulation of liver VLDL receptor and FAT/CD36 expression in LDLR-/- apoB100/100 mice fed trans-10,cis-12 conjugated linoleic acid. Degrace P, Moindrot B, Mohamed I, Gresti J, Du ZY, Chardigny JM, Sebedio JL, Clouet P, J Lipid Res 2006 47 2647 2655 10.1194/jlr.M600140-JLR200 16957181 (Pubitemid 44936078)
84. Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents. Ota T, Gayet C, Ginsberg HN, J Clin Invest 2008 118 316 332 10.1172/JCI32752 18060040
85. Apolipoprotein B100 acts as a molecular link between lipid-induced endoplasmic reticulum stress and hepatic insulin resistance. Su Q, Tsai J, Xu E, Qiu W, Bereczki E, Santha M, Adeli K, Hepatology 2009 50 77 84 10.1002/hep.22960 19434737
86. Roles of phosphatidate phosphatase enzymes in lipid metabolism. Carman GM, Han GS, Trends Biochem Sci 2006 31 694 699 10.1016/j.tibs.2006.10.003 17079146 (Pubitemid 44791946)
87. Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Peterfy M, Phan J, Xu P, Reue K, Nat Genet 2001 27 121 124 10.1038/83685 11138012 (Pubitemid 32044532)
88. Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns. Donkor J, Sariahmetoglu M, Dewald J, Brindley DN, Reue K, J Biol Chem 2007 282 3450 3457 10.1074/jbc.M610745200 17158099 (Pubitemid 47084457)
89. Alternatively spliced lipin isoforms exhibit distinct expression pattern, subcellular localization, and role in adipogenesis. Peterfy M, Phan J, Reue K, J Biol Chem 2005 280 32883 32889 10.1074/jbc.M503885200 16049017 (Pubitemid 41368337)
90. Glucocorticoids and cyclic AMP selectively increase hepatic lipin-1 expression, and insulin acts antagonistically. Manmontri B, Sariahmetoglu M, Donkor J, Bou Khalil M, Sundaram M, Yao Z, Reue K, Lehner R, Brindley DN, J Lipid Res 2008 49 1056 1067 10.1194/jlr.M800013-JLR200 18245816
91. The level and compartmentalization of phosphatidate phosphatase-1 (lipin-1) control the assembly and secretion of hepatic VLDL. Bou Khlail M, Sundaram M, Zhang HY, Links PH, Raven JF, Manmontri B, Sariahmetoglu M, Tran K, Reue K, Brindley DN, et al. J Lipid Res 2009 50 47 58 18769019
92. Alterations in hepatic metabolism in fld mice reveal a role for lipin 1 in regulating VLDL-triacylglyceride secretion. Chen Z, Gropler MC, Norris J, Lawrence JC Jr, Harris TE, Finck BN, Arterioscler Thromb Vasc Biol 2008 28 1738 1744 10.1161/ATVBAHA.108.171538 18669885
93. Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway. Finck BN, Gropler MC, Chen Z, Leone TC, Croce MA, Harris TE, Lawrence JC Jr, Kelly DP, Cell Metab 2006 4 199 210 10.1016/j.cmet.2006.08.005 16950137 (Pubitemid 44283957)
94. Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members. Cases S, Stone SJ, Zhou P, Yen E, Tow B, Lardizabal KD, Voelker T, Farese RV Jr, J Biol Chem 2001 276 38870 38876 10.1074/jbc.M106219200 11481335
95. Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Cases S, Smith SJ, Zheng YW, Myers HM, Lear SR, Sande E, Novak S, Collins C, Welch CB, Lusis AJ, et al. Proc Natl Acad Sci USA 1998 95 13018 13023 10.1073/pnas.95.22.13018 9789033 (Pubitemid 28509516)
96. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Smith SJ, Cases S, Jensen DR, Chen HC, Sande E, Tow B, Sanan DA, Raber J, Eckel RH, Farese RV Jr, Nat Genet 2000 25 87 90 10.1038/75651 10802663 (Pubitemid 30257043)
97. Short-term overexpression of DGAT1 or DGAT2 increases hepatic triglyceride but not VLDL triglyceride or apoB production. Millar JS, Stone SJ, Tietge UJ, Tow B, Billheimer JT, Wong JS, Hamilton RL, Farese RV Jr, Rader DJ, J Lipid Res 2006 47 2297 2305 10.1194/jlr.M600213-JLR200 16877777 (Pubitemid 44936140)
98. Overexpression of human diacylglycerol acyltransferase 1, acyl-coa:cholesterol acyltransferase 1, or acyl-CoA:cholesterol acyltransferase 2 stimulates secretion of apolipoprotein B-containing lipoproteins in McA-RH7777 cells. Liang JJ, Oelkers P, Guo C, Chu PC, Dixon JL, Ginsberg HN, Sturley SL, J Biol Chem 2004 279 44938 44944 10.1074/jbc.M408507200 15308631 (Pubitemid 39430907)
99. Increased very low density lipoprotein secretion and gonadal fat mass in mice overexpressing liver DGAT1. Yamazaki T, Sasaki E, Kakinuma C, Yano T, Miura S, Ezaki O, J Biol Chem 2005 280 21506 21514 10.1074/jbc.M412989200 15797871 (Pubitemid 40805716)
100. Knockdown of acyl-CoA:diacylglycerol acyltransferase 2 with antisense oligonucleotide reduces VLDL TG and ApoB secretion in mice. Liu Y, Millar JS, Cromley DA, Graham M, Crooke R, Billheimer JT, Rader DJ, Biochim Biophys Acta 2008 1781 97 104 18252207
101. Disruption of the murine gene encoding phosphatidylethanolamine N-methyltransferase. Walkey CJ, Donohue LR, Bronson R, Agellon LB, Vance DE, Proc Natl Acad Sci USA 1997 94 12880 12885 10.1073/pnas.94.24.12880 9371769 (Pubitemid 27518445)
102. Lack of phosphatidylethanolamine N-methyltransferase alters plasma VLDL phospholipids and attenuates atherosclerosis in mice. Zhao Y, Su B, Jacobs RL, Kennedy B, Francis GA, Waddington E, Brosnan JT, Vance JE, Vance DE, Arterioscler Thromb Vasc Biol 2009 29 1349 1355 10.1161/ATVBAHA.109.188672 19520976
103. Physiological consequences of disruption of mammalian phospholipid biosynthetic genes. Vance DE, Vance JE, J Lipid Res 2009 50 Suppl 132 S137 10.1194/jlr.R800048-JLR200 18955728
104. Targeted deletion of hepatic CTP:phosphocholine cytidylyltransferase alpha in mice decreases plasma high density and very low density lipoproteins. Jacobs RL, Devlin C, Tabas I, Vance DE, J Biol Chem 2004 279 47402 47410 10.1074/jbc.M404027200 15331603 (Pubitemid 39518397)
105. Hepatic CTP:phosphocholine cytidylyltransferase-alpha is a critical predictor of plasma high density lipoprotein and very low density lipoprotein. Jacobs RL, Lingrell S, Zhao Y, Francis GA, Vance DE, J Biol Chem 2008 283 2147 2155 10.1074/jbc.M706628200 18042552
106. Genomic organization and differential splicing of the mouse and human Pcyt2 genes. Poloumienko A, Cote A, Quee AT, Zhu L, Bakovic M, Gene 2004 325 145 155 10.1016/j.gene.2003.10.005 14697519 (Pubitemid 38030385)
107. The development of a metabolic disease phenotype in CTP: phosphoethanolamine cytidylyltransferase-deficient mice. Fullerton MD, Hakimuddin F, Bonen A, Bakovic M, J Biol Chem 2009 284 25704 25713 10.1074/jbc.M109.023846 19625253
108. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Li Z, Agellon LB, Allen TM, Umeda M, Jewell L, Mason A, Vance DE, Cell Metab 2006 3 321 331 10.1016/j.cmet.2006.03. 007 16679290
109. Apolipoprotein B100 exit from the endoplasmic reticulum (ER) is COPII-dependent, and its lipidation to very low density lipoprotein occurs post-ER. Gusarova V, Brodsky JL, Fisher EA, J Biol Chem 2003 278 48051 48058 10.1074/jbc.M306898200 12960170 (Pubitemid 37523255)
110. Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders. Jones B, Jones EL, Bonney SA, Patel HN, Mensenkamp AR, Eichenbaum-Voline S, Rudling M, Myrdal U, Annesi G, Naik S, et al. Nat Genet 2003 34 29 31 10.1038/ng1145 12692552 (Pubitemid 36548786)
111. Role of ADP ribosylation factor 1 in the assembly and secretion of ApoB-100-containing lipoproteins. Asp L, Magnusson B, Rutberg M, Li L, Boren J, Olofsson SO, Arterioscler Thromb Vasc Biol 2005 25 566 570 10.1161/01.ATV. 0000154135.21689.47 15618550 (Pubitemid 40315679)
112. ADP-ribosylation factor 1 and its activation of phospholipase D are important for the assembly of very low density lipoproteins. Asp L, Claesson C, Boren J, Olofsson SO, J Biol Chem 2000 275 26285 26292 10.1074/jbc.M003520200 10843997
113. Brefeldin A reversibly inhibits the assembly of apoB containing lipoproteins in McA-RH7777 cells. Rustaeus S, Lindberg K, Boren J, Olofsson SO, J Biol Chem 1995 270 28879 28886 10.1074/jbc.270.48.28879 7499415
114. Adipocyte differentiation-related protein promotes fatty acid storage in cytosolic triglycerides and inhibits secretion of very low-density lipoproteins. Magnusson B, Asp L, Bostrom P, Ruiz M, Stillemark-Billton P, Linden D, Boren J, Olofsson SO, Arterioscler Thromb Vasc Biol 2006 26 1566 1571 10.1161/01.ATV.0000223345.11820.da 16627799 (Pubitemid 44288984)
115. Cideb, an ER- and lipid droplet-associated protein, mediates VLDL lipidation and maturation by interacting with apolipoprotein B. Ye J, Li JZ, Liu Y, Li X, Yang T, Ma X, Li Q, Yao Z, Li P, Cell Metab 2009 9 177 190 10.1016/j.cmet.2008.12.013 19187774
116. Cidea-deficient mice have lean phenotype and are resistant to obesity. Zhou Z, Yon TS, Chen Z, Guo K, Ng CP, Ponniah S, Lin SC, Hong W, Li P, Nat Genet 2003 35 49 56 10.1038/ng1225 12910269 (Pubitemid 37048595)
117. Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E- deficient mouse hepatocytes. Kuipers F, Jong MC, Lin Y, Eck M, Havinga R, Bloks V, Verkade HJ, Hofker MH, Moshage H, Berkel TJ, et al. J Clin Invest 1997 100 2915 2922 10.1172/JCI119841 9389759 (Pubitemid 28007563)
118. Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver. Mensenkamp AR, Jong MC, van GH, Van Luyn MJ, Bloks V, Havinga R, Voshol PJ, Hofker MH, van Dijk KW, Havekes LM, et al. J Biol Chem 1999 274 35711 35718 10.1074/jbc.274.50.35711 10585451 (Pubitemid 129512872)
119. Hepatic apolipoprotein E expression promotes very low density lipoprotein-apolipoprotein B production in vivo in mice. Maugeais C, Tietge UJ, Tsukamoto K, Glick JM, Rader DJ, J Lipid Res 2000 41 1673 1679 11013310
120. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia. Huang Y, Liu XQ, Rall SC Jr, Taylor JM, von EA, Assmann G, Mahley RW, J Biol Chem 1998 273 26388 26393 10.1074/jbc.273.41.26388 9756870 (Pubitemid 28471643)
121. Golgi-associated maturation of very low density lipoproteins involves conformational changes in apolipoprotein B, but is not dependent on apolipoprotein E. Gusarova V, Seo J, Sullivan ML, Watkins SC, Brodsky JL, Fisher EA, J Biol Chem 2007 282 19453 19462 10.1074/jbc.M700475200 17500069 (Pubitemid 47100087)
122. Structure and dynamics of human apolipoprotein CIII. Gangabadage CS, Zdunek J, Tessari M, Nilsson S, Olivecrona G, Wijmenga SS, J Biol Chem 2008 283 17416 17427 10.1074/jbc.M800756200 18408013
123. Functional analysis of the missense APOC3 mutation Ala23Thr associated with human hypotriglyceridemia. Sundaram M, Zhong S, Bou Khalil M, Zhou H, Jiang ZG, Zhao Y, Iqbal J, Hussain MM, Figeys D, Wang Y, et al. J Lipid Res 2010
124. Characterization of the lipid-binding properties and lipoprotein lipase inhibition of a novel apolipoprotein C-III variant Ala23Thr. Liu H, Labeur C, Xu CF, Ferrell R, Lins L, Brasseur R, Rosseneu M, Weiss KM, Humphries SE, Talmud PJ, J Lipid Res 2000 41 1760 1771 11060345
125. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, Krauss RM, Rubin EM, Science 2001 294 169 173 10.1126/science.1064852 11588264 (Pubitemid 32952971)
126. The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism? van Dijk KW, Rensen PC, Voshol PJ, Havekes LM, Curr Opin Lipidol 2004 15 239 246 10.1097/00041433-200406000-00002 15166778 (Pubitemid 38716555)
127. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. Schaap FG, Rensen PC, Voshol PJ, Vrins C, van d V, Chamuleau RA, Havekes LM, Groen AK, van Dijk KW, J Biol Chem 2004 279 27941 27947 10.1074/jbc.M403240200 15090553 (Pubitemid 38900062)
128. Intracellular lipid droplet targeting by apolipoprotein A-V requires the carboxyl-terminal segment. Shu X, Ryan RO, Forte TM, J Lipid Res 2008 49 1670 1676 10.1194/jlr.M800111-JLR200 18450648
129. The role of the LDL receptor in apolipoprotein B secretion. Twisk J, Gillian-Daniel DL, Tebon A, Wang L, Barrett PH, Attie AD, J Clin Invest 2000 105 521 532 10.1172/JCI8623 10683382
130. Apolipoprotein B metabolism in homozygous familial hypercholesterolemia. James RW, Martin B, Pometta D, Fruchart JC, Duriez P, Puchois P, Farriaux JP, Tacquet A, Demant T, Clegg RJ, et al. J Lipid Res 1989 30 159 169 2715722 (Pubitemid 19067221)
131. Stimulation of the in vivo production of very low density lipoproteins by apolipoprotein E is independent of the presence of the low density lipoprotein receptor. Teusink B, Mensenkamp AR, van der BH, Kuipers F, van Dijk KW, Havekes LM, J Biol Chem 2001 276 40693 40697 10.1074/jbc.M106396200 11546779
132. The unstirred water layer as a site of control of apolipoprotein B secretion. Williams KJ, Brocia RW, Fisher EA, J Biol Chem 1990 265 16741 16744 2170353
133. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. Jiang XC, Qin S, Qiao C, Kawano K, Lin M, Skold A, Xiao X, Tall AR, Nat Med 2001 7 847 852 10.1038/89977 11433351 (Pubitemid 32691641)
134. Regulation of ApoB secretion by the low density lipoprotein receptor requires exit from the endoplasmic reticulum and interaction with ApoE or ApoB. Blasiole DA, Oler AT, Attie AD, J Biol Chem 2008 283 11374 11381 10.1074/jbc.M710457200 18272520
135. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation. Seidah NG, Benjannet S, Wickham L, Marcinkiewicz J, Jasmin SB, Stifani S, Basak A, Prat A, Chretien M, Proc Natl Acad Sci USA 2003 100 928 933 10.1073/pnas.0335507100 12552133 (Pubitemid 36183932)
136. Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype. Maxwell KN, Breslow JL, Proc Natl Acad Sci USA 2004 101 7100 7105 10.1073/pnas.0402133101 15118091 (Pubitemid 38596449)
137. Evidence for effect of mutant PCSK9 on apolipoprotein B secretion as the cause of unusually severe dominant hypercholesterolaemia. Sun XM, Eden ER, Tosi I, Neuwirth CK, Wile D, Naoumova RP, Soutar AK, Hum Mol Genet 2005 14 1161 1169 10.1093/hmg/ddi128 15772090 (Pubitemid 40613905)
138. Wild-type PCSK9 inhibits LDL clearance but does not affect apoB-containing lipoprotein production in mouse and cultured cells. Lalanne F, Lambert G, Amar MJ, Chetiveaux M, Zair Y, Jarnoux AL, Ouguerram K, Friburg J, Seidah NG, Brewer HB Jr, et al. J Lipid Res 2005 46 1312 1319 10.1194/jlr.M400396-JLR200 15741654 (Pubitemid 43109846)
139. Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9. Rashid S, Curtis DE, Garuti R, Anderson NN, Bashmakov Y, Ho YK, Hammer RE, Moon YA, Horton JD, Proc Natl Acad Sci USA 2005 102 5374 5379 10.1073/pnas.0501652102 15805190 (Pubitemid 40530265)
140. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. Clee SM, Kastelein JJ, van DM, Marcil M, Roomp K, Zwarts KY, Collins JA, Roelants R, Tamasawa N, Stulc T, et al. J Clin Invest 2000 106 1263 1270 10.1172/JCI10727 11086027
141. A novel role for ABCA1-generated large pre-beta migrating nascent HDL in the regulation of hepatic VLDL triglyceride secretion. Chung S, Gebre AK, Seo J, Shelness GS, Parks JS, J Lipid Res 2010 51 729 742 10.1194/jlr.M900083 20215580
142. Phosphoinositide 3-kinase activity is necessary for insulin-dependent inhibition of apolipoprotein B secretion by rat hepatocytes and localizes to the endoplasmic reticulum. Phung TL, Roncone A, Jensen KL, Sparks CE, Sparks JD, J Biol Chem 1997 272 30693 30702 10.1074/jbc.272.49.30693 9388205 (Pubitemid 27527502)
143. Scavenger receptor BI facilitates hepatic very low density lipoprotein production in mice. Wiersma H, Nijstad N, Gautier T, Iqbal J, Kuipers F, Hussain MM, Tietge UJ, J Lipid Res 2010 51 544 553 10.1194/jlr.M000844 19723664
144. New perspectives on atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism. Ginsberg HN, Circulation 2002 106 2137 2142 10.1161/01.CIR.0000035280.64322.31 12379586 (Pubitemid 35192822)
145. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Meshkani R, Adeli K, Clin Biochem 2009 42 1331 1346 10.1016/j.clinbiochem.2009.05.018 19501581
146. Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. Taghibiglou C, Carpentier A, Van Iderstine SC, Chen B, Rudy D, Aiton A, Lewis GF, Adeli K, J Biol Chem 2000 275 8416 8425 10.1074/jbc.275.12.8416 10722675 (Pubitemid 30180185)
147. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production. Tsai J, Zhang R, Qiu W, Su Q, Naples M, Adeli K, Am J Physiol Gastrointest Liver Physiol 2009 296 1287 G1298 10.1152/ajpgi.90540.2008 19342510
148. Hepatic VLDL production in ob/ob mice is not stimulated by massive de novo lipogenesis but is less sensitive to the suppressive effects of insulin. Wiegman CH, Bandsma RH, Ouwens M, Sluijs van der FH, Havinga R, Boer T, Reijngoud DJ, Romijn JA, Kuipers F, Diabetes 2003 52 1081 1089 10.2337/diabetes.52.5.1081 12716736 (Pubitemid 36523340)
149. Obesity in db and ob animals leads to impaired hepatic very low density lipoprotein secretion and differential secretion of apolipoprotein B-48 and B-100. Li X, Grundy SM, Patel SB, J Lipid Res 1997 38 1277 1288 9254055 (Pubitemid 27332556)
150. Cholesteryl ester transfer protein expression prevents diet-induced atherosclerotic lesions in male db/db mice. MacLean PS, Bower JF, Vadlamudi S, Osborne JN, Bradfield JF, Burden HW, Bensch WH, Kauffman RF, Barakat HA, Arterioscler Thromb Vasc Biol 2003 23 1412 1415 10.1161/01.ATV.0000080687.94313. 67 12791674 (Pubitemid 36994530)
151. Obesity causes very low density lipoprotein clearance defects in low-density lipoprotein receptor-deficient mice. Coenen KR, Gruen ML, Hasty AH, J Nutr Biochem 2007 18 727 735 10.1016/j.jnutbio.2006.12.010 17418556 (Pubitemid 47600650)
152. Dietary sucrose is essential to the development of liver injury in the MCD model of steatohepatitis. Pickens MK, Yan JS, Ng RK, Ogata H, Grenert JP, Beysen C, Turner SM, Maher JJ, J Lipid Res 2009 50 2072 2082 10.1194/jlr.M900022-JLR200 19295183
153. Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet. Rinella ME, Elias MS, Smolak RR, Fu T, Borensztajn J, Green RM, J Lipid Res 2008 49 1068 1076 10.1194/jlr.M800042-JLR200 18227531
154. The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. Yao ZM, Vance DE, J Biol Chem 1988 263 2998 3004 3343237 (Pubitemid 18062955)
155. The role of liver × receptor-alpha in the fatty acid regulation of hepatic gene expression. Pawar A, Botolin D, Mangelsdorf DJ, Jump DB, J Biol Chem 2003 278 40736 40743 10.1074/jbc.M307973200 12917410 (Pubitemid 37280889)
156. LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins. Basciano H, Miller A, Baker C, Naples M, Adeli K, Am J Physiol Gastrointest Liver Physiol 2009 297 323 G332 10.1152/ajpgi.90546.2008 19497957
157. Liver triglyceride secretion and lipid oxidative metabolism are rapidly altered by leptin in vivo. Huang W, Dedousis N, Bandi A, Lopaschuk GD, O'Doherty RM, Endocrinology 2006 147 1480 1487 10.1210/en.2005-0731 16339207 (Pubitemid 43244383)
158. Hepatic steatosis and plasma dyslipidemia induced by a high-sucrose diet are corrected by an acute leptin infusion. Huang W, Dedousis N, O'Doherty RM, J Appl Physiol 2007 102 2260 2265 10.1152/japplphysiol.01449.2006 17363621 (Pubitemid 47080758)
159. Impaired activation of phosphatidylinositol 3-kinase by leptin is a novel mechanism of hepatic leptin resistance in diet-induced obesity. Huang W, Dedousis N, Bhatt BA, O'Doherty RM, J Biol Chem 2004 279 21695 21700 10.1074/jbc.M401546200 14993225 (Pubitemid 38679354)
160. Leptin augments the acute suppressive effects of insulin on hepatic very low-density lipoprotein production in rats. Huang W, Metlakunta A, Dedousis N, Ortmeyer HK, Stefanovic-Racic M, O'Doherty RM, Endocrinology 2009 150 2169 2174 10.1210/en.2008-1271 19147673
161. Altered triglyceride-rich lipoprotein production in Zucker diabetic fatty rats. Chirieac DV, Collins HL, Cianci J, Sparks JD, Sparks CE, Am J Physiol Endocrinol Metab 2004 287 42 E49 10.1152/ajpendo.00297.2003 14970003 (Pubitemid 38856280)
162. Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. Taghibiglou C, Carpentier A, Van Iderstine SC, Chen B, Rudy D, Aiton A, Lewis GF, Adeli K, J Biol Chem 2000 275 8416 8425 10.1074/jbc.275.12.8416 10722675 (Pubitemid 30180185)
163. Co-translational degradation of apolipoprotein B100 by the proteasome is prevented by microsomal triglyceride transfer protein. Synchronized translation studies on HepG2 cells treated with an inhibitor of microsomal triglyceride transfer protein. Benoist F, Grand-Perret T, J Biol Chem 1997 272 20435 20442 10.1074/jbc.272.33.20435 9252352 (Pubitemid 27355596)
164. The degradation of apolipoprotein B100 is mediated by the ubiquitin-proteasome pathway and involves heat shock protein 70. Fisher EA, Zhou M, Mitchell DM, Wu X, Omura S, Wang H, Goldberg AL, Ginsberg HN, J Biol Chem 1997 272 20427 20434 10.1074/jbc.272.33.20427 9252351 (Pubitemid 27355595)
165. Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation into the endoplasmic reticulum. Liao W, Yeung SC, Chan L, J Biol Chem 1998 273 27225 27230 10.1074/jbc.273.42.27225 9765244 (Pubitemid 28500433)
166. Role of lipid synthesis, chaperone proteins and proteasomes in the assembly and secretion of apoprotein B-containing lipoproteins from cultured liver cells. Ginsberg HN, Clin Exp Pharmacol Physiol 1997 24 29 A32 10.1111/j.1440-1681.1997.tb03051.x 9143794
167. The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism. Ginsberg HN, Fisher EA, J Lipid Res 2009 50 Suppl 162 S166 10.1194/jlr.R800090-JLR200 19050312
168. Apolipoprotein B in the rough endoplasmic reticulum: translation, translocation and the initiation of lipoprotein assembly. Shelness GS, Ingram MF, Huang XF, DeLozier JA, J Nutr 1999 129 456S 462S 10064309 (Pubitemid 29069645)
169. Intracellular degradation of newly synthesized apolipoprotein B. Yao Z, Tran K, McLeod RS, J Lipid Res 1997 38 1937 1953 9374117 (Pubitemid 27468003)
170. Autophagy. Mortimore GE, Miotto G, Venerando R, Kadowaki M, Subcell Biochem 1996 27 93 135 8993159
171. Structural aspects of autophagy. Seglen PO, Berg TO, Blankson H, Fengsrud M, Holen I, Stromhaug PE, Adv Exp Med Biol 1996 389 103 111 8860999
172. Autophagy: many paths to the same end. Cuervo AM, Mol Cell Biochem 2004 263 55 72 10.1023/B:MCBI.0000041848.57020.57 15524167 (Pubitemid 39256145)
173. Cytoplasmic lipid droplets are sites of convergence of proteasomal and autophagic degradation of apolipoprotein B. Ohsaki Y, Cheng J, Fujita A, Tokumoto T, Fujimoto T, Mol Biol Cell 2006 17 2674 2683 10.1091/mbc.E05-07-0659 16597703 (Pubitemid 43825504)